Efficacy News and Research

RSS

Omicron-specific mRNA vaccine provides superior immune protection against two viral subvariants

Yale scientists have developed a novel Omicron-specific mRNA vaccine that offers superior immune protection against two viral subvariants than standard mRNA vaccines.

20 Jul 2022

New way to test vaccines may be as rigorous and stringent as exposure to field strains of malaria

Malaria is the deadliest mosquito-borne parasitic infection of humans. In 2021, after a century of research, the World Health Organization (WHO) approved the world's first malaria vaccine.

20 Jul 2022

CDC experts update on monkeypox in the United States

Scientists working with the CDC provide the latest information about monkeypox in the U.S.

19 Jul 2022

Gut-lung axis: Using commensal bacteria to reinforce mucosal immunity

A recent study discusses the use of commensal bacteria in the gut and/or respiratory tract to deliver viral antigens to the host, thus acting as vaccines

19 Jul 2022

Scientists explore guanine-specific pocket in SARS-CoV-2 nucleocapsid protein of therapeutic value against multiple coronaviruses

Researchers studied open and closed conformations of the C-terminal of SARS-CoV-2 nucleocapsid (N) protein termed the NCTD.

19 Jul 2022

Could Vitamin B6 Reduce Anxiety and Depression?

In this interview, we speak to Dr. David Field about his latest research into anxiety and depression and whether vitamin B6 supplements could help to reduce it.

19 Jul 2022

What is the efficacy of the second, third, and fourth dose of the COVID-19 mRNA vaccine?

Investigators examined the effectiveness of two, three, and four SARS-CoV-2 vaccine doses during the Omicron prevalent phases.

19 Jul 2022

Should siRNA-based antivirals be added to the COVID toolbox?

A recent study reviewed the existing treatment modalities, including vaccines and antivirals, for SARS-CoV-2 infection.

19 Jul 2022

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

AbbVie today announced it has submitted a marketing authorization application to the European Medicines Agency for atogepant for the prophylaxis of migraine in adult patients who have at least four migraine days per month.

From AbbVie 19 Jul 2022

Americans least likely to be prepared to take necessary actions during disasters, study shows

A new national study shows that Americans are least likely to be prepared to take necessary actions when faced with disasters such as hurricanes, floods and wildfires.

19 Jul 2022

Anti-rejection drug plus immunotherapy could change the lives of kidney transplant patients with cancer

Adding immunotherapy to standard anti-rejection medication could change the lives of thousands of kidney transplant patients with incurable cancer, as new research shows it can reduce this risk of organ rejection and eliminate cancer in a quarter of patients.

18 Jul 2022

Prostaglandin E1 could enhance the safety of ECMO

In case of heart and/or lung failure, an ECMO machine can be used to maintain organ function for days or even weeks.

18 Jul 2022

Scientists develop an improved pharmaceutical drug for the treatment of atrial fibrillation

Scientists from the National University of Singapore Department of Pharmacy have developed an improved pharmaceutical drug for the treatment of the most common heart rhythm disturbance – atrial fibrillation (AF).

18 Jul 2022

What is the impact of lower COVID-19 vaccine doses in younger cohorts?

A new study evaluated the impact of the lower SARS-CoV-2 vaccine dosages in younger populations.

18 Jul 2022

Nitazoxanide drug found to be a potent inhibitor of several human coronaviruses

Researchers evaluated the activity of nitazoxanide against human coronaviruses (HCoVs).

18 Jul 2022

Scientists evaluate immunostimulatory glycolipid against SARS-CoV-2 infection

A new study showed that 7DW8-5, an immunostimulatory glycolipid impeded three respiratory viral infections, including SARS-CoV-2, in vivo.

18 Jul 2022

How effective is the fourth dose of COVID-19 vaccines in the elderly and long-term care residents?

Researchers evaluated the efficacy of the fourth dose of coronavirus disease 2019 vaccine in residents of long-term care facilities.

18 Jul 2022

Cytokine-based cancer immunotherapy: current progress and future prospects

In this interview, News-Medical talks to Dr. Shuang Zhou about cytokine-base cancer immunotherapy, the current state of the field, and future prospects.

From Sino Biological Inc. 18 Jul 2022

Study shows that older adults can generate robust, long-lived memory against SARS-CoV-2 following infection

Researchers reported on the benefit of immunity developed by previous SARS-CoV-2 infection for overcoming the age-associated decline in COVID-19 vaccine effectiveness.

18 Jul 2022

Study results encourage SARS-CoV-2–infected mothers breastfeed to protect infants from COVID

A new study examines the strength of protection against COVID-19 using antibody concentrations at birth and after six months in mothers and children.

17 Jul 2022

Efficacy News and Research

Omicron-specific mRNA vaccine provides superior immune protection against two viral subvariants

New way to test vaccines may be as rigorous and stringent as exposure to field strains of malaria

CDC experts update on monkeypox in the United States

Gut-lung axis: Using commensal bacteria to reinforce mucosal immunity

Scientists explore guanine-specific pocket in SARS-CoV-2 nucleocapsid protein of therapeutic value against multiple coronaviruses

Could Vitamin B6 Reduce Anxiety and Depression?

What is the efficacy of the second, third, and fourth dose of the COVID-19 mRNA vaccine?

Should siRNA-based antivirals be added to the COVID toolbox?

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

Americans least likely to be prepared to take necessary actions during disasters, study shows

Anti-rejection drug plus immunotherapy could change the lives of kidney transplant patients with cancer

Prostaglandin E1 could enhance the safety of ECMO

Scientists develop an improved pharmaceutical drug for the treatment of atrial fibrillation

What is the impact of lower COVID-19 vaccine doses in younger cohorts?

Nitazoxanide drug found to be a potent inhibitor of several human coronaviruses

Scientists evaluate immunostimulatory glycolipid against SARS-CoV-2 infection

How effective is the fourth dose of COVID-19 vaccines in the elderly and long-term care residents?

Cytokine-based cancer immunotherapy: current progress and future prospects

Study shows that older adults can generate robust, long-lived memory against SARS-CoV-2 following infection

Study results encourage SARS-CoV-2–infected mothers breastfeed to protect infants from COVID

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News